Yoko Narasaki , Amy S. You , Ira Kurtz , Niloofar Nobakht , Mohammad Kamgar , Man Kit Michael Siu , Rebecca S. Ahdoot , Ramy Hanna , Sara S. Kalantar , Jihoon Yoon , Lisa Le , Silvina Torres Rivera , Tracy Nakata , Ria Arora , Danh V. Nguyen , Kamyar Kalantar-Zadeh , Connie M. Rhee
{"title":"Sleep Patterns, Symptoms, and Mortality in Hemodialysis: A Prospective Cohort Study","authors":"Yoko Narasaki , Amy S. You , Ira Kurtz , Niloofar Nobakht , Mohammad Kamgar , Man Kit Michael Siu , Rebecca S. Ahdoot , Ramy Hanna , Sara S. Kalantar , Jihoon Yoon , Lisa Le , Silvina Torres Rivera , Tracy Nakata , Ria Arora , Danh V. Nguyen , Kamyar Kalantar-Zadeh , Connie M. Rhee","doi":"10.1016/j.xkme.2025.100976","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale & Objective</h3><div>While sleep disorders are common in patients treated with hemodialysis, the impact of sleep patterns on survival is not well defined. We thus examined the association of specific sleep patterns with mortality in this population.</div></div><div><h3>Study Design</h3><div>An observational cohort study.</div></div><div><h3>Setting & Population</h3><div>In-center hemodialysis patients from the multicenter prospective NIH Malnutrition, Diet, and Racial Disparities in Chronic Kidney Disease (MADRAD) cohort.</div></div><div><h3>Exposure</h3><div>Sleep patterns ascertained using protocolized sleep surveys from March 2014 to June 2019.</div></div><div><h3>Outcomes</h3><div>Mortality.</div></div><div><h3>Analytical Approach</h3><div>Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Among 452 participants, the mean age was 55±14 years, among whom 46% were women and the median follow-up was 3.5 years. In expanded case-mix models, shorter sleep duration (≤ median of observed values) was associated with higher mortality on dialysis and nondialysis days (ref: > median): HRs (95% CIs) 1.59 (1.09-2.31) and 1.51 (1.04-2.19), respectively. Patients who reported high frequencies (often/almost always) of difficulty falling asleep, feeling unrested, fatigue/exhaustion post-dialysis, or fatigue/exhaustion on nondialysis days had higher mortality (ref: never/rarely having these symptoms): HRs (95% CIs) 1.74 (1.17-2.58), 1.69 (1.1-2.5), 2.42 (1.41-4.16), and 1.73 (1.11-2.69), respectively. Moderate to high frequency of sleeping pill use was associated with higher mortality (ref: never/rare use): HRs (95% CIs) 2.07 (1.08, 3.97) and 2.00 (1.22, 3.28) for sometimes and often/almost always using sleeping pills, respectively. Sleeping outside of the primary sleep period (intra-dialytic sleeping and napping) was not associated with worse survival. However, patients reporting frequent apnea or restless legs syndrome had higher mortality.</div></div><div><h3>Limitations</h3><div>Potential recall bias, residual confounding, absence of time-varying observations, and limitations in generalizability.</div></div><div><h3>Conclusions</h3><div>In a well-characterized prospective multicenter hemodialysis cohort, patients who reported shorter sleep duration, sleeping difficulty or feeling unrested, moderate to frequent sleeping pill consumption, and sleep disorders (apnea and restless legs) had a higher mortality risk.</div></div><div><h3>Plain Language Summary</h3><div>Patients with kidney failure have a high burden of sleep disorders. However, the relationship between sleeping problems and the health of patients treated with dialysis is not well understood. To address this knowledge gap, we examined the relationship between various types of sleep disturbances and associated symptoms with survival among a diverse cohort of patients treated with hemodialysis from the multicenter prospective NIH Malnutrition, Diet, and Racial Disparities in Chronic Kidney Disease (MADRAD) study. We found that patients who reported shorter sleep duration, sleeping difficulty or feeling unrested, moderate to frequent sleeping pill consumption, and sleep disorders such as apnea or restless legs syndrome had a higher death risk.</div></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":"7 4","pages":"Article 100976"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059525000123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale & Objective
While sleep disorders are common in patients treated with hemodialysis, the impact of sleep patterns on survival is not well defined. We thus examined the association of specific sleep patterns with mortality in this population.
Study Design
An observational cohort study.
Setting & Population
In-center hemodialysis patients from the multicenter prospective NIH Malnutrition, Diet, and Racial Disparities in Chronic Kidney Disease (MADRAD) cohort.
Exposure
Sleep patterns ascertained using protocolized sleep surveys from March 2014 to June 2019.
Outcomes
Mortality.
Analytical Approach
Cox proportional hazards models.
Results
Among 452 participants, the mean age was 55±14 years, among whom 46% were women and the median follow-up was 3.5 years. In expanded case-mix models, shorter sleep duration (≤ median of observed values) was associated with higher mortality on dialysis and nondialysis days (ref: > median): HRs (95% CIs) 1.59 (1.09-2.31) and 1.51 (1.04-2.19), respectively. Patients who reported high frequencies (often/almost always) of difficulty falling asleep, feeling unrested, fatigue/exhaustion post-dialysis, or fatigue/exhaustion on nondialysis days had higher mortality (ref: never/rarely having these symptoms): HRs (95% CIs) 1.74 (1.17-2.58), 1.69 (1.1-2.5), 2.42 (1.41-4.16), and 1.73 (1.11-2.69), respectively. Moderate to high frequency of sleeping pill use was associated with higher mortality (ref: never/rare use): HRs (95% CIs) 2.07 (1.08, 3.97) and 2.00 (1.22, 3.28) for sometimes and often/almost always using sleeping pills, respectively. Sleeping outside of the primary sleep period (intra-dialytic sleeping and napping) was not associated with worse survival. However, patients reporting frequent apnea or restless legs syndrome had higher mortality.
Limitations
Potential recall bias, residual confounding, absence of time-varying observations, and limitations in generalizability.
Conclusions
In a well-characterized prospective multicenter hemodialysis cohort, patients who reported shorter sleep duration, sleeping difficulty or feeling unrested, moderate to frequent sleeping pill consumption, and sleep disorders (apnea and restless legs) had a higher mortality risk.
Plain Language Summary
Patients with kidney failure have a high burden of sleep disorders. However, the relationship between sleeping problems and the health of patients treated with dialysis is not well understood. To address this knowledge gap, we examined the relationship between various types of sleep disturbances and associated symptoms with survival among a diverse cohort of patients treated with hemodialysis from the multicenter prospective NIH Malnutrition, Diet, and Racial Disparities in Chronic Kidney Disease (MADRAD) study. We found that patients who reported shorter sleep duration, sleeping difficulty or feeling unrested, moderate to frequent sleeping pill consumption, and sleep disorders such as apnea or restless legs syndrome had a higher death risk.